Abstract. Chronic kidney disease (CKD) is recognized as a risk factor not only for end-stage renal disease but also for cardiovascular disease. Early detection and treatment of CKD is a likely key factor for prevention of its complications. Although genetic linkage analyses and association studies have implicated several loci and candidate genes in predisposition to CKD, the genes that underlie genetic susceptibility to this condition have remained largely unknown. The purpose of the present study was to identify genetic variants that confer susceptibility to CKD in Japanese individuals. The study population comprised 4,829 Japanese individuals (2,697 men, 2,132 women), including 757 subjects with CKD [464 men, 293 women; estimated glomerular filtration rate (eGFR) <50 ml min 1.73 m -2 ] and 4,072 controls (2,233 men, 1,839 women; eGFR ≥60 ml min 1.73 m -2 ). The genotypes for 40 polymorphisms of 39 candidate genes were determined. The chi-square test, multivariable logistic regression analysis with adjustment for covariates, as well as a stepwise forward selection procedure revealed that six polymorphisms of F10, PITRM1, PCSK2, JPH3, MYO7B, and AKAP12 were related (P<0.05) to the prevalence of CKD. Among these polymorphisms, the C→T polymorphism of F10 (rs5962) was most significantly associated with this condition. Determination of genotypes for the C→T polymorphism of F10 may prove informative for assessment of genetic risk for CKD in Japanese individuals.
Introduction
A current epidemic of chronic kidney disease (CKD) is a major health problem worldwide. In Japan, the number of new patients with end-stage renal disease (ESRD) has been increasing during the last four decades (1) . Individuals with CKD are at increased risk not only for ESRD but also for a poor cardiovascular outcome and premature death (2, 3) . Disease prevention is an important strategy for reducing the overall burden of CKD and ESRD, and the identification of markers for disease risk is essential both for risk prediction and for potential intervention to reduce the chance of future cardiovascular events (4) .
Although genetic linkage analyses (5) and association studies (6) (7) (8) (9) (10) have implicated several loci and candidate genes in predisposition to CKD, the genes that confer susceptibility to this condition remain to be identified definitively. In addition, given the ethnic differences in lifestyle and environmental factors as well as in genetic background and renal function, it is important to examine genetic variants related to CKD in each ethnic group. We have now performed an association study for 40 polymorphisms of 39 candidate genes and CKD in 4,829 Japanese individuals. The purpose of the present study was to identify genetic variants that confer susceptibility to CKD and thereby to provide a basis for the personalized prevention of this condition.
Materials and methods
Study population. The study population comprised 4,829 unrelated Japanese individuals (2,697 men, 2,132 women) who either visited outpatient clinics of or were admitted to one of the participating hospitals (Gifu Prefectural General Medical Center and Gifu Prefectural Tajimi Hospital in Gifu Prefecture, Japan; and Hirosaki University Hospital, Reimeikyo Rehabilitation Hospital, and Hirosaki Stroke Center in Aomori Prefecture, Japan) between October 2002 and March 2008 because of various symptoms or for an annual health checkup, or who were recruited to a population-based prospective cohort study of aging and age-related diseases in Gunma Prefecture, Japan.
Estimated glomerular filtration rate (eGFR) was calculated with the use of the simplified prediction equation derived from the modified version of that described in the Modification of Diet in Renal Disease (MDRD) Study as proposed by the Japanese Society of Nephrology (11) , eGFR (ml min Table I . The 40 polymorphisms examined in the present study. Table II . Primers, probes, and other PCR conditions for genotyping of polymorphisms related (P-value for allele frequency <0.05) to chronic kidney disease. -
markedly when values fall <45 ml min -1 1.73 m -2 (12) . In addition, the rate of GFR decline was significantly higher in Japanese individuals younger than 70 years with an initial value of <50 ml min -1 1.73 m -2 , suggestive of a poor outcome for such individuals (13) . We thus adopted the criterion of an eGFR of <50 ml min -1 1.73 m -2 for diagnosis of CKD in the present study. On the basis of this criterion, 757 subjects (464 men, 293 women) were diagnosed with CKD. The control subjects comprised 4,072 individuals (2,233 men, 1,839 women) whose eGFR was ≥60 ml min -1 1.73 m -2 . The control subjects were recruited from community-dwelling healthy individuals or the patients who visited outpatient clinics regularly for treatment of various common diseases. Subjects with CKD and controls thus either had or did not have conventional risk factors for CKD, including hypertension (systolic blood pressure of ≥140 mmHg or diastolic blood pressure of ≥90 mmHg, or both, or taking antihypertensive medication), diabetes mellitus (fasting blood glucose of ≥6.93 mmol/l or hemoglobin A 1c of ≥6.5%, or both, or taking antidiabetes medication), or hypercholesterolemia (serum total cholesterol of ≥5.72 mmol/l or taking lipid-lowering medication). The study protocol complied with the Declaration of Helsinki and was approved by the Committees on the Ethics of Human Research of Mie University Graduate School of Medicine, Hirosaki University Graduate School of Medicine, Gifu International Institute of Biotechnology, Tokyo Metropolitan Institute of Gerontology, and participating hospitals. Written informed consent was obtained from each participant.
Selection of polymorphisms.
Our aim was to identify genetic variants associated with CKD in the Japanese population in a case-control association study by examining the relations of candidate gene polymorphisms to this condition. Polymorphisms examined in the present study (Table I) were selected from genome-wide association studies of ischemic stroke (14) and myocardial infarction. Given that atherosclerosis is an important risk factor for CKD (15) , genetic variants related to atherosclerotic disease such as ischemic stroke and myocardial infarction might also contribute to the development of CKD. We have not examined the relation of these polymorphisms in the previous studies (7, 8, (16) (17) (18) (19) .
Genotyping of polymorphisms. Venous blood (7 ml) was collected into tubes containing 50 mmol/l ethylenediaminetetraacetic acid (disodium salt), and genomic DNA was isolated with a kit (Genomix; Talent, Trieste, Italy). Genotypes of the 40 polymorphisms were determined at G&G Science (Fukushima, Japan) by a method that combines the polymerase chain reaction (PCR) and sequence-specific oligonucleotide probes with suspension array technology (Luminex, Austin, TX). Primers, probes, and other PCR conditions for genotyping polymorphisms found to be related (P-value for allele frequency of <0.05) to CKD by the chi-square test are shown in Table II . Detailed genotyping methodology was described previously (20) .
Statistical analysis. Quantitative data were compared between subjects with CKD and controls by the unpaired Student's t test. Categorical data were compared by the chi-square test. Allele frequencies were estimated by the gene counting method, and the chi-square test was used to identify departures from Hardy-Weinberg equilibrium. In the initial screen, the allele frequencies of each polymorphism were compared between subjects with CKD and controls by the chi-square test. Given the multiple comparisons of genotypes with CKD, the false discovery rate (FDR) was calculated from the distribution of P values for allele frequency of the 40 polymorphisms (21) . Polymorphisms with a P-value for allele frequency of <0.05 Table III . Characteristics of subjects with chronic kidney disease (CKD) and controls. 
Quantitative data are means ±SD. HDL, high density lipoprotein; eGFR, estimated glomerular filtration rate.
-
were further examined by multivariable logistic regression analysis with adjustment for covariates. Multivariable logistic regression analysis was thus performed with CKD as a dependent variable and independent variables including age, sex (0, woman; 1, man), body mass index (BMI), smoking status (0, nonsmoker; 1, smoker), history of hypertension, diabetes mellitus, or hypercholesterolemia (0, no history; 1, positive history), and genotype of each polymorphism, and the P-value, odds ratio, and 95% confidence interval were calculated. Each genotype was assessed according to dominant, recessive, and additive genetic models. Additive models included the additive 1 model (heterozygotes versus wild-type homozygotes) and the additive 2 model (variant homozygotes versus wildtype homozygotes), which were analyzed simultaneously with a single statistical model. We also performed a stepwise forward selection procedure to examine the effects of genotypes as well as of other covariates on CKD; each genotype was examined according to a dominant or recessive model on the basis of statistical significance in the multivariable logistic regression analysis. The P-levels for inclusion in and exclusion Table IV . Genotype distributions of polymorphisms related (P-value for allele frequency <0.05) to chronic kidney disease (CKD) as determined by the chi-square test. 
Controls a P-value FDR -----------------------------------------------------------------------------------------------------
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a Numbers in parentheses are percentages.
from the model were 0.25 and 0.1, respectively. With the exception of the initial screen by the chi-square test (FDR <0.05), a P-value of <0.05 was considered statistically significant. Statistical significance was examined by two-sided tests performed with JMP version 6.0 and JMP Genomics version 3.2 software (SAS Institute, Cary, NC).
Results
The characteristics of the 4,829 study subjects are shown in Table III . Age, the frequency of male subjects, systolic blood pressure, serum concentrations of triglycerides and creatinine, fasting plasma glucose level, blood glycosylated hemoglobin content, and the prevalence of hypertension, diabetes mellitus, and hypercholesterolemia were greater, whereas serum concentration of high density lipoprotein (HDL)-cholesterol, eGFR, and the percentage of smokers were lower in subjects with CKD than in controls.
Comparison of allele frequencies with the chi-square test revealed that 10 polymorphisms were related (P-value of <0.05 for allele frequency) to the prevalence of CKD (Table IV) . Among these polymorphisms, the C➝T polymorphism of F10 (rs5962) was significantly (FDR <0.05) associated with this condition. The genotype distributions of all 10 polymorphisms, with the exception of the C➝T polymorphism of TRAPPC9 in control subjects, were in Hardy-Weinberg equilibrium both in individuals with CKD and in controls (Table V) ; the C➝T polymorphism of TRAPPC9 was therefore excluded from subsequent analysis.
Multivariable logistic regression analysis with adjustment for age, sex, BMI, smoking status, and the prevalence of hypertension, diabetes mellitus, and hypercholesterolemia revealed that the C➝T polymorphism of F10 (dominant and additive 1 models), the C➝G polymorphism of PITRM1 (dominant and additive 2 models), the C➝G polymorphism of PCSK2 (dominant and additive 2 models), the C➝G polymorphism of JPH3 (dominant and additive 1 models), the C➝T polymorphism of MYO7B (dominant and additive 1 models), the C➝T polymorphisms of MARCH10 (recessive model), and the A➝G polymorphism of AKAP12 (recessive - Table VI . Multivariable logistic regression analysis of polymorphisms related (allele frequency <0.05) to chronic kidney disease by the chi-square test.
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Gene symbol 
OR, odds ratio; CI, confidence interval. Multivariable logistic regression analysis was performed with adjustment for age, sex, body mass index, smoking status, and the prevalence of hypertension, diabetes mellitus, and hypercholesterolemia. P-values of <0.05 are shown in bold.
were significantly (P<0.05) associated with the prevalence of CKD (Table VI) . The T allele of F10, G allele of PCSK2, T allele of MYO7B, and G allele of AKAP12 were risk factors for CKD, whereas the G allele of PITRM1, G allele of JPH3, and T allele of MARCH10 were protective against this condition. Finally, we performed a stepwise forward selection procedure to examine the effects of genotypes for the seven polymorphisms associated with CKD by multivariable logistic regression analysis as well as of age, sex, BMI, smoking status, and the prevalence of hypertension, diabetes mellitus, and hypercholesterolemia on CKD (Table VII) . Age, diabetes mellitus, hypertension, sex, smoking, F10 genotype (dominant model), AKAP12 genotype (recessive model), MYO7B genotype (dominant model), JPH3 genotype (dominant model), PCSK2 genotype (dominant model), PITRM1 genotype (dominant model), and hypercholesterolemia, in descending order of statistical significance, were significant (P<0.05) and independent determinants of CKD.
Discussion
We examined the possible relations of 40 gene polymorphisms to the prevalence of CKD in 4,829 Japanese individuals. Our association study with three steps of analysis (chi-square test, multivariable logistic regression analysis, and stepwise forward selection procedure) revealed that the C➝T polymorphism of F10 was significantly (FDR <0.05) associated with CKD in such individuals, with the T allele representing a risk factor for this condition.
Coagulation factor X (F10), the zymogen of a vitamin K-dependent serine protease, plays a pivotal role in the coagulation cascade (22) . It can be activated through either the contact-activated (intrinsic) pathway or the tissue-factor (extrinsic) pathway (23) . F10 is composed of light and heavy chains held together by a disulfide bond (24) as well as synthesized in the liver as a single-chain molecule (25) . Activated F10 catalyzes the conversion of prothrombin to thrombin in the presence of phospholipids and calcium ions (26) . Thrombin then converts fibrinogen to insoluble fibrin. F10 deficiency results in a serious bleeding disorder which points to an essential role for F10 in hemostasis (22) .
F10 is located at chromosome 13q34 in close proximity to F7 and spans ~25 kilobases, containing eight exons (27) . The overall domain structure of F10 is highly homologous to that of the other vitamin K-dependent coagulation factors. F10 is primarily expressed in the liver (28) . The -40C➝T polymorphism in the promoter region of F10 was previously associated with coronary heart disease, with the T allele representing a risk factor for this condition (29) . However, another study did not detect the relation of this polymorphism to plasma F10 level or to thrombosis risk (30) . Although the deleterious influence of the T allele on coronary heart disease cannot be explained by its effect on the circulating level of F10, the previous observation (29) suggested F10 as a candidate susceptibility gene for atherothrombotic disease. We have now shown that the C➝T polymorphism of F10 was significantly associated with the prevalence of CKD, with the T allele representing a risk factor for CKD. Effects of this polymorphism on the development of atherothrombosis may account for its association with CKD. Given that the T allele frequency of this polymorphism was low, validation of our findings is required in large independent subject panels.
Our results suggest that PITRM1, PCSK2, JPH3, MYO7B, and AKAP12 were also candidate genes for CKD in Japanese individuals. The proprotein convertase 2 gene (PCSK2) encodes the insulin processing protease. The variant of this gene was shown to be associated with type 2 diabetes mellitus in Japanese individuals, with the A1 allele (21 CA repeats) representing a risk factor for this condition (31) . Although mutations in certain myosins can cause diseases in humans and mice (32) , the myosin-VIIb gene (MYO7B) has not been related to human disease. An antibody to MYO7B labeled proximal tubule cells of the kidney, specifically the distal tips of apical microvilli on these transporting epithelial cells (33) . These observations implicate MYO7B as a candidate susceptibility gene for renal dysfunction. The A kinase anchor protein 12 (AKAP12) was originally identified as a cytoplasmic antigen recognized by myasthenia gravis sera (34) . The expression of Akap12 was decreased by hypoxia and upregulated by reoxygenation at the transcriptional level in rats (35) . We have now shown that the C➝G polymorphism of PCSK2, the C➝T polymorphism of MYO7B, and the A➝G polymorphism of AKAP12 were associated with CKD, with the G, T, and G alleles, respectively, representing risk factors for this condition, although the underlying mechanisms remain to be determined.
The pitrilysin metallopeptidase 1 gene (PITRM1) is located at chromosome 10p15.2. The mitochondrial PITRM1 functions as a peptide scavenger in the mitochondrial matrix, clearing mitochondria from toxic peptides and protecting them against pathogenic peptide intruders (36). Polymorphisms of PITRM1 have not been related to human disease. JPH3 encodes junctophilin-3, a member of a conserved family of proteins that are components of junctional complexes (37). Holmes et al (38) demonstrated a CAG/CTG repeat expansion of ≥40 triplets in an alternatively spliced exon of JPH3 in affected members of an African American family with Huntington disease-like 2. 
-------------------------------------------------
, contribution rate.
We have now shown that the C➝G polymorphism of PITRM1 and the C➝G polymorphism of JPH3 were associated with CKD, with both G alleles protecting against this condition, although the molecular mechanisms remain unclear. Our study has several limitations: (i) we used eGFR instead of directly measured GFR to define CKD, (ii) we have not obtained information on the underlying renal disease or the primary cause of CKD in each subject with CKD. Such information could be obtained by detailed clinical examination, including renal biopsy, but such diagnostic procedures are not considered feasible for a study whose subjects are recruited from the general population, (iii) it is possible that one or more of the polymorphisms associated with CKD in the present study are in linkage disequilibrium with other polymorphisms in the same gene or in other nearby genes that are actually responsible for the development of this condition, (iv) the functional relevance of the identified polymorphisms to gene transcription or to protein structure or function was not determined in the present study, (v) although we adopted the criterion of FDR <0.05 for association to compensate for the multiple comparisons of genotypes with CKD, it is not possible to exclude completely potential statistical errors such as false positives, (vi) although a previous study (39) showed smoking to be a risk factor for CKD, the frequency of smoking was lower in subjects with CKD than in controls in the present study. Selection bias thus could not be excluded completely in the present study.
In conclusion, our present results suggest that the C➝T polymorphism of F10 is significantly associated with CKD in Japanese individuals. Determination of genotype for this polymorphism may prove informative for assessment of the genetic risk for CKD in such individuals. Validation of our findings will require their replication with independent subject panels as well as long-term follow-up to examine the association of the identified genetic variants with the rate of decline in eGFR.
